← Back to Search

Radiation for Non-Small Cell Lung Cancer

N/A
Waitlist Available
Led By Joshua Weir, MD
Research Sponsored by West Virginia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the start of treatment until disease progression up to 2 years.
Awards & highlights

Study Summary

This trial will use radiation therapy in addition to immunotherapy to see if it improves non-small cell lung cancer response to immunotherapy and to watch for any side effects.

Eligible Conditions
  • Non-small Cell Lung Cancer Metastatic

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the start of treatment until disease progression up to 2 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from the start of treatment until disease progression up to 2 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best Overall Response
Secondary outcome measures
Adverse event evaluation
Overall Survival
Progression Free Survival
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Radiation Therapy + ImmunotherapyExperimental Treatment2 Interventions
3-5 fraction course of radiation therapy to target lesion concurrent with an immuno-therapeutic agent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiation
2003
Completed Phase 3
~1020
Immuno-Therapeutic Agent
2017
N/A
~40

Find a Location

Who is running the clinical trial?

West Virginia UniversityLead Sponsor
175 Previous Clinical Trials
56,271 Total Patients Enrolled
West Virginia Clinical and Translational Science InstituteOTHER
7 Previous Clinical Trials
65 Total Patients Enrolled
Joshua Weir, MDPrincipal InvestigatorWVUCI - Mary Babb Randolph Cancer Center
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still the opportunity to sign up for this research project?

"Clinicialtrials.gov has indicated that this trial is no longer recruiting candidates, as it was initially posted on January 23rd 2017 and last updated April 25th 2022. However, 1912 other trials are still open to new patients at the current time."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
2017. "Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03035890.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top